Please login to the form below

Not currently logged in
Email:
Password:

diabetes

This page shows the latest diabetes news and features for those working in and with pharma, biotech and healthcare.

Another Alzheimer's bust as Merck stops verubecestat study

Another Alzheimer's bust as Merck stops verubecestat study

Since the start of the year, Boehringer Ingelheim has stopped development of its PDE9a inhibitor BI 4093906, Takeda and Zinfandel abandoned efforts to repurpose diabetes drug pioglitazone for the disease, and

Latest news

More from news
Approximately 342 fully matching, plus 1,077 partially matching documents found.

Latest Intelligence

  • Reading human behaviour to create a medical future Reading human behaviour to create a medical future

    Triggers. Two examples already in their evidence bank show both how simple changes can be and how important behaviour is to outcomes: a group of diabetes patients came up with a ... improve. “Now, we are now at a stage where the biggest causes of

  • Warning signs Warning signs

    You can see some of these dynamics already playing in the diabetes area - but much more is coming.”.

  • Positive disruption in business intelligence Positive disruption in business intelligence

    In an analysis of 47, 000 UK HCP posts about type 2 diabetes, 58% of mentions of named drugs were about drug trial data. ... While some high-profile clinical trials were mentioned by name during congress meetings, HCP mentions of drug trials in type 2

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    Ignoring the scientific evidence that sugar is addictive, accelerates the onset of diabetes and that our bodies instantly turn half of it into fat is irresponsible and ultimately self-harming.

  • Tools for the digital world Tools for the digital world

    However, some schemes have produced concrete results. For example, MSD partnered with Celesio on an intervention programme which improved adherence to diabetes medication by up to 61%. ... Samuel Pygall, pharmacy strategy lead for MSD, said the company

More from intelligence
Approximately 12 fully matching, plus 125 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 53 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 87 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics